tirzepatide pdufa In just under three years, Eli Lilly's outpaced Merck's Keytruda, reaching $35 billion in sales compared to Keytruda's $31.8 billion by 2025 FDA Grants Tirzepatide a New
Description
Mounjaro starts at 2.5 mg weekly for four weeks, then increases to 5 mg
On its own, GIP does not have a strong effect in people with type 2 diabetes
Lilly claims this structural feature as a key innovation for once-weekly dosing
24 weeks 24 syringes Add a few extras for dropped or damaged syringes
Neither the FDA-approved prescribing information for tirzepatide nor published clinical guidelines explicitly address sermorelin co-administration
But averages hide important details
